I guess since it is now Friday and no news as yet on iv trial then that is indirectly news in itself. Theoretically all who were dosed in this batch would have been reviewed yesterday so we should be able to say at least there were no serious side effects otherwise they would be obliged to announce?
so in theory now we have r327 appears to be effective in curing chronic burns infections within 7 days in surface treatments, and it would appear no major side effects in sepsis iv trial. Shareprice just starting what appears to be a slow burn up to a dollar. Hopefully that is just the fuse before the rocket takes off. Even the shorters seem to have finally started reducing their positions again
Best wishes to all holders for Christmas. Hopefully next year is when we show the world the answer to sepsis and multi drug resistant infections is finally here and real. Congratulations and best wishes to everyone at Rce on results to date.
RCE Price at posting:
$1.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)